F-Star Therapeutics Inc (NASDAQ:FSTX)
| 4.94 Delayed Data As of Feb 01 |  +0.83 / +20.19%Today’s Change | 2.07 Today|||52-Week Range 6.93 | -21.84% Year-to-Date |
Latest FSTX News | Press Releases
No recent news for F-Star Therapeutics Inc.
Today’s Trading
| Previous close | 4.11 |
| Today’s open | 4.97 |
| Day’s range | 4.65 - 5.15 |
| Volume | 1,959,967 |
| Average volume (3 months) | 430,305 |
| Market cap | $92.5M |
Data as of 3:59pm ET, 02/01/2023
Growth & Valuation
| Earnings growth (last year) | +80.61% |
| Earnings growth (this year) | -46.33% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +88.05% |
| P/E ratio | NM |
| Price/Sales | 3.95 |
| Price/Book | 0.91 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SPHDFSanthera Pharmaceuti... | 0.00 | 0.00% |
| THTXTheratechnologies In... | -0.00 | -0.19% |
| ETONEton Pharmaceuticals... | 0.00 | 0.00% |
| ACHVAchieve Life Science... | +0.18 | +3.70% |
Data as of 3:59pm ET, 02/01/2023
Financials
| Next reporting date | March 27, 2023 |
| EPS forecast (this quarter) | -$0.55 |
| Annual revenue (last year) | $21.2M |
| Annual profit (last year) | -$31.3M |
| Net profit margin | -147.79% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
